Sumatriptan and Naratriptan Tolerability and Safety: An Update of Post-Marketing Experience
- 1 September 2001
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 21 (1_suppl) , 25-28
- https://doi.org/10.1046/0333102401021s0109
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Effects of the Anti-Migraine Drug Sumatriptan on Muscle Energy Metabolism: Relationship to Side-EffectsCephalalgia, 2000
- Hemodynamic and coronary effects of intravenous eletriptan, a 5HT -receptor agonistClinical Pharmacology & Therapeutics, 1999
- Coronary Side-Effect Potential of Current and Prospective Antimigraine DrugsCirculation, 1998
- Abnormal brain and muscle energy metabolism shown by 31 P magnetic resonance spectroscopy in patients affected by migraine with auraNeurology, 1992
- 5-hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activationEuropean Journal of Pharmacology, 1989